<SEC-DOCUMENT>0001213900-17-003359-index.html : 20170405
<SEC-HEADER>0001213900-17-003359.hdr.sgml : 20170405
<ACCEPTANCE-DATETIME>20170405092902
ACCESSION NUMBER:		0001213900-17-003359
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20170405
FILED AS OF DATE:		20170405
DATE AS OF CHANGE:		20170405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Therapix Biosciences Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1213

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38041
		FILM NUMBER:		17741268

	BUSINESS ADDRESS:	
		STREET 1:		SCIENCE PARK, 18 EINSTIEN ST.
		STREET 2:		P.O BOX 4122
		CITY:			NESS-ZIONA
		STATE:			L3
		ZIP:			7414002
		BUSINESS PHONE:		972-8-9396577

	MAIL ADDRESS:	
		STREET 1:		SCIENCE PARK, 18 EINSTIEN ST.
		STREET 2:		P.O BOX 4122
		CITY:			NESS-ZIONA
		STATE:			L3
		ZIP:			7414002
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>f6k040517_therapixbio.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: f6k040517_therapixbio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f6k040517ex99i_therapixbio.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON APRIL 5, 2017, ANNOUNCING IT HAS SIGNED AN EXCLUSIVE LICENSE AGREEMENT WITH YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY LTD. FOR YISSUM'S NASAL DRUG DELIVERY TECHNOLOGY
<TEXT>
Document 2 - file: f6k040517ex99i_therapixbio.htm

</DOCUMENT>
</SEC-DOCUMENT>